If you respect someone, let them go? Personal autonomy and physical safety in psychedelic treatments
Christopher Poppe, Chiara Caporuscio, Dimitris Repantis
JME Practical Bioethics July 1, 2026 DOI: 10.1136/jmepb-2025-000048 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | Argues that containment during psychedelic dosing sessions should be justified under weak paternalism, implemented using the least restrictive means, and operationalized through enhanced informed consent rather than blanket requirements to remain on-site. |
Abstract
Psychedelic treatments hold significant therapeutic promise for various psychiatric conditions. However, their unique therapeutic setting with psychedelic substance dosing sessions presents a particular ethical issue concerning patient autonomy. This article explores the ethics of limiting personal autonomy and freedom of movement during dosing sessions due to concerns for physical safety. After outlining normative reasons guiding clinical decision-making to uphold personal autonomy and physical safety in other medical contexts, we propose that containment during psychedelic dosing sessions should be justified under weak paternalism, implemented using the least restrictive means and operationalised through enhanced informed consent rather than blanket requirements to remain on-site.
Citations in the library
Cites 20
- Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Biological Psychiatry February 1, 2023
- Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Journal of Psychopharmacology February 9, 2015
- Ethics and ego dissolution: the case of psilocybin Journal of Medical Ethics May 27, 2020
- Psilocybin-assisted therapy for depression: A systematic review and meta-analysis. Psychiatry Research November 1, 2023
- Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants The International Journal of Neuropsychopharmacology November 4, 2022
and 15 more in the library